Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Current Liabilities: 2015-2020

Historic Total Current Liabilities for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $18.5 million.

  • Outlook Therapeutics' Total Current Liabilities fell 20.52% to $18.5 million in Q2 2020 from the same period last year, while for Jun 2020 it was $18.5 million, marking a year-over-year decrease of 20.52%. This contributed to the annual value of $20.3 million for FY2019, which is 36.68% down from last year.
  • Per Outlook Therapeutics' latest filing, its Total Current Liabilities stood at $18.5 million for Q2 2020, which was down 22.15% from $23.7 million recorded in Q1 2020.
  • Over the past 5 years, Outlook Therapeutics' Total Current Liabilities peaked at $39.3 million during Q2 2017, and registered a low of $18.5 million during Q2 2020.
  • Its 3-year average for Total Current Liabilities is $25.6 million, with a median of $25.3 million in 2019.
  • In the last 5 years, Outlook Therapeutics' Total Current Liabilities tumbled by 44.83% in 2016 and then soared by 71.20% in 2017.
  • Over the past 5 years, Outlook Therapeutics' Total Current Liabilities (Quarterly) stood at $32.1 million in 2016, then dropped by 2.89% to $31.2 million in 2017, then dropped by 11.75% to $27.5 million in 2018, then dropped by 27.00% to $20.1 million in 2019, then fell by 20.52% to $18.5 million in 2020.
  • Its Total Current Liabilities was $18.5 million in Q2 2020, compared to $23.7 million in Q1 2020 and $20.1 million in Q4 2019.